BRIC CGM Market, Forecast By Users & CGM Components | Renub Research
BRIC CGM market will reach US$ 868 Million by 2025. Users, Reimbursement Policy, CGM Components (Glucose Sensor, Transmitter), Diabetes (Type1 & 2) Population, & Forecast.
By: Renub Research
The BRIC CGM market is driven mainly by the increasing numbers of people with diabetes across BRIC countries, growing diabetes research, and increasing international research collaborations. The Continuous Positive Cost-Effective Analysis by BRICS Countries and rapid urbanization and CGM Technology Convenient for both Patients & Physicians are further expected to contribute to the growth of this CGM market. However, Controversy regarding Clinical Benefits and the high cost of diabetes care devices are the remonstrance growth of this market.
In the year Feb 2019, Senseonics made a distribution agreement with Roche Diabetes Care for two years, giving exclusive rights to the Big Biotech for selling implantable glucose monitoring systems in Brazil, Russia, India, and China. The continuous glucose monitoring (CGM) devices market in BRIC countries are set to thrive regardless of the major upheaval caused by the COVID-19 pandemic. The surging demand for CGM in BRIC countries are primarily driven by a growing awareness of the devices and companies' quick responses to the COVID-19 epidemic.
Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-
Phone No: +1 678-302-0700 (USA) | +91-120-421-
Follow the Link for Report Customization: